To Cure Cancers
With Innovation and Speed

Committed to fight cancers with cutting-edge technologies
and innovative combination therapies, driven by a passionate team
Learn More
T cell
Cancer
hero-image-arrow Created with Sketch.

Our Mission

To bring curative treatments to cancer patients
Pipeline
Unique portfolio of antibodies, vaccines, adjuvants and adoptive cell therapies
People
Team of innovative scientists and professionals
Our Innovation Engine
Novel technology platforms that deliver innovation with speed.

Our Pipeline

We are targeting multiple mechanisms to fight cancer with
single agent and combination Therapies
Pipeline at-a-glance >
Training the immune
system to recognize cancers
Cancer Vaccines
Expanding and
mobilizing immune cells
Priming Agents
CTLA-4, CD137
Accelerating immune attack,
blocking immune resistance
Immune Checkpoints
PD-1, CTLA-4, CD137,
TIGIT, LAG-3, TIM-3,
etc...
Creating Inroads,
removing barriers
Tumor Microenvironment Conditioners
Bispecifics
(undisclosed)

Our Innovation Engine

We have state-of-the-art technology and manufacturing
platforms to repeatedly innovate with speed

Publications, Presentations
& Other Stories

Newsletters
Read Newsletters >
Scientific Conference
Presentations
View Presentations >
Journal
Publications
Read Publications >
Investor
Presentations
View Presentations >